Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Innovation Pharmaceuticals IPIX
(Total Views: 475)
Posted On: 10/23/2019 10:12:07 AM
Post# of 72447
Avatar
Posted By: Drano
J&J's Crohn's Disease drug fails in clinical trial -- BUT, the clinical trial is suspect because the response to placebo was an astonishing 85%. If a placebo could get these kinds of results, we wouldn't really NEED real drugs for something as devastating as Crohn's.
Where have we seen unusually high placebo response affecting apparent results before? Hmm, let me think.....

https://endpts.com/provention-bios-jj-license...age-study/

So it isn't just small companies that get unusually high placebo responses messing up their clinical trials. But it USUALLY is small companies that magically are affected by this problem.

It's time to stop giving patients placebos and start using population data as the control group, so that this kind of nonsense (or shenanigans) doesn't affect the futures of potentially helpful drugs.













(4)
(1)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site